Annovis Bio, Inc. (FRA:07X)
Germany flag Germany · Delayed Price · Currency is EUR
2.340
-0.020 (-0.85%)
At close: Jan 30, 2026

Annovis Bio Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
606717410312542
Market Cap Growth
-6.81%-61.39%69.23%-18.07%194.78%-
Enterprise Value
4755168738335
Last Close Price
2.344.9618.0012.1415.805.30
PB Ratio
5.377.46-24.763.873.206.89
P/TBV Ratio
5.377.46-3.873.206.89
Quick Ratio
4.092.721.353.6930.3313.96
Current Ratio
4.603.592.394.6830.5414.04
Return on Equity (ROE)
-246.14%-3159.09%-546.40%-69.57%-55.68%-180.82%
Return on Assets (ROA)
-105.88%-138.26%-121.77%-38.88%-33.58%-89.86%
Return on Capital Employed (ROCE)
-198.60%-265.80%-759.60%-90.10%-32.70%-88.10%
Earnings Yield
-35.21%-35.43%-29.29%-23.10%-10.17%-10.51%
Buyback Yield / Dilution
-61.36%-35.60%-10.55%-7.03%-20.88%-2132.36%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.